Creation and validation of models to predict response to primary treatment in serous ovarian cancer

Abstract Nearly a third of patients with high-grade serous ovarian cancer (HGSC) do not respond to initial therapy and have an overall poor prognosis. However, there are no validated tools that accurately predict which patients will not respond. Our objective is to create and validate accurate model...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Jesus Gonzalez Bosquet, Eric J. Devor, Andreea M. Newtson, Brian J. Smith, David P. Bender, Michael J. Goodheart, Megan E. McDonald, Terry A. Braun, Kristina W. Thiel, Kimberly K. Leslie
Format: article
Langue:EN
Publié: Nature Portfolio 2021
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/f68931067a254b7db52a837c8291c2da
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!